Denali Therapeutics
DNLI
#4216
Rank
S$3.42 B
Marketcap
S$21.96
Share price
0.06%
Change (1 day)
-18.24%
Change (1 year)

Market capitalization of Denali Therapeutics (DNLI)

Market cap: S$3.42 Billion

As of January 2026 Denali Therapeutics has a market cap of S$3.42 Billion. This makes Denali Therapeutics the world's 4216th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Denali Therapeutics from 2017 to 2026

End of year Market Cap

Year Marketcap Change
2026S$3.42 B1.4%
2025S$3.38 B-16.11%
2024S$4.03 B2.94%
2023S$3.91 B-22.65%
2022S$5.06 B-31.24%
2021S$7.36 B-44.59%
2020S$13.28 B488.22%
2019S$2.25 B-15.45%
2018S$2.67 B45.18%
2017S$1.84 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Denali Therapeutics was reported to be:

S$3.42 Billion
by Nasdaq info icon info icon
S$3.42 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novocure
NVCR
S$2.06 B-39.75% Jersey
Novavax
NVAX
S$1.51 B-55.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
S$4.72 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
S$0.48 B-85.75%๐Ÿ‡ฌ๐Ÿ‡ง UK